The Situation
____________
A Pharmaceutical company with an FDA-approved treatment for Dyskinesia in Parkinson’s patients aimed to strategically expand into therapies for off-episodes. To effectively navigate an evolving and competitive treatment landscape, the client needed continuous, detailed insights into clinical and commercial developments.
The Solution
____________
Sedulo Group designed a tailored early warning monitoring program, combining meticulous analysis of press releases, investor presentations, earnings calls, analyst reports, clinical data publications, and competitor activities. Primary Research Specialists at Sedulo conducted targeted interviews with competitor personnel in marketing, medical affairs, and investor relations. Regular monthly meetings were conducted to ensure alignment on priorities, supplemented by timely email alerts and detailed coverage of key industry events such as AAN and MDS conferences.
The areas of focus for this program were:
- Dyskinesia in people with Parkinson’s
- OFF episodes in people with Parkinson’s
The Success
____________
Leveraging continuous, timely insights provided by Sedulo Group, the client proactively adjusted their strategic initiatives and confidently responded to market developments. Equipped with a thorough understanding of competitor moves and emerging treatment dynamics, the client effectively optimized their strategic positioning, accelerated decision-making, and confidently pursued their goals in advancing Parkinson’s therapies for Dyskinesia and OFF episodes.